{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T04:49:20Z","timestamp":1794458960444,"version":"4.9.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG 278529602 - SFB1243 (A11, A12)"],"award-info":[{"award-number":["DFG 278529602 - SFB1243 (A11, A12)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WE 4679\/2-1"],"award-info":[{"award-number":["WE 4679\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG 278529602 - SFB1243 (A14)"],"award-info":[{"award-number":["DFG 278529602 - SFB1243 (A14)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG 278529602 - SFB1243 (A14)"],"award-info":[{"award-number":["DFG 278529602 - SFB1243 (A14)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WE 4679\/2-1"],"award-info":[{"award-number":["WE 4679\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG 278529602 - SFB1243 (A01)"],"award-info":[{"award-number":["DFG 278529602 - SFB1243 (A01)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["DFG 278529602 - SFB 1243 (A10)"],"award-info":[{"award-number":["DFG 278529602 - SFB 1243 (A10)"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["2018.087.1"],"award-info":[{"award-number":["2018.087.1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 338\/1 2021 \u2013 452881907"],"award-info":[{"award-number":["SFB 338\/1 2021 \u2013 452881907"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 338\/1 2021 \u2013 451580403"],"award-info":[{"award-number":["SFB 338\/1 2021 \u2013 451580403"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008672","name":"Wilhelm Sander-Stiftung","doi-asserted-by":"publisher","award":["2022.093.1"],"award-info":[{"award-number":["2022.093.1"]}],"id":[{"id":"10.13039\/100008672","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2021_EKES.13"],"award-info":[{"award-number":["2021_EKES.13"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001219","name":"Lymphoma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Impuls-und Vernetzungsfonds of the Helmholtz-Gemeinschaft"},{"name":"Munich Medical & Clinician Scientist Program"},{"name":"Else Kr\u00f6ner Fresenius Clinican Scientist Program"},{"name":"Cyliax foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Differ"],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The cell death receptor FAS and its ligand (FASLG) play crucial roles in the selection of B cells during the germinal center (GC) reaction. Failure to eliminate potentially harmful B cells via FAS can lead to lymphoproliferation and the development of\u00a0B cell malignancies. The classic form of follicular lymphoma (FL) is a prototypic GC-derived B cell malignancy, characterized by the t(14;18)(q32;q21)IGH::<jats:italic>BCL2<\/jats:italic> translocation and overexpression of antiapoptotic BCL2. Additional alterations were shown to be clinically relevant, including mutations in <jats:italic>ARID1A<\/jats:italic>. ARID1A is part of the SWI\/SNF nucleosome remodeling complex that regulates DNA accessibility (\u201copenness\u201d). However, the mechanism how <jats:italic>ARID1A<\/jats:italic> mutations contribute to FL pathogenesis remains unclear. We analyzed 151 FL biopsies of patients with advanced-stage disease at initial diagnosis and found that <jats:italic>ARID1A<\/jats:italic> mutations were recurrent and mainly disruptive, with an overall frequency of 18%. Additionally, we observed that <jats:italic>ARID1A<\/jats:italic> mutant FL showed significantly lower FAS protein expression in the FL tumor cell population. Functional experiments in BCL2-translocated lymphoma cells demonstrated that ARID1A is directly involved in the regulation of FAS, and ARID1A loss leads to decreased FAS protein and gene expression. However, ARID1A loss did not affect <jats:italic>FAS<\/jats:italic> promotor openness. Instead, we identified and experimentally validated a previously unknown co-transcriptional complex consisting of RUNX3 and ETS1 that regulates <jats:italic>FAS<\/jats:italic> expression, and ARID1A loss leads to reduced <jats:italic>RUNX3<\/jats:italic> promotor openness and gene expression. The reduced FAS levels induced by ARID1A loss rendered lymphoma cells resistant to both soluble and T cell membrane-anchored FASLG-induced apoptosis, and significantly diminished CAR T cell killing in functional experiments. In summary, we have identified a functionally and clinically relevant mechanism how FL cells can escape FAS-dependent immune surveillance, which may also impact the efficacy of T cell-based therapies, including CAR T cells.<\/jats:p>","DOI":"10.1038\/s41418-025-01445-3","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T23:23:01Z","timestamp":1737588181000},"page":"899-910","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["ARID1A mutations protect follicular lymphoma from FAS-dependent immune surveillance by reducing RUNX3\/ETS1-driven FAS-expression"],"prefix":"10.1038","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2720-9886","authenticated-orcid":false,"given":"Martina","family":"Antoniolli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Solovey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5451-8038","authenticated-orcid":false,"given":"Johannes Adrian","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabea","family":"Freyholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin Dorothea","family":"Strobl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Bararia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William David","family":"Keay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4308-2423","authenticated-orcid":false,"given":"Louisa","family":"Adolph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3275-9156","authenticated-orcid":false,"given":"Lucas","family":"Wange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Enard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Thieme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3994-2332","authenticated-orcid":false,"given":"Helmut","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rudelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4332-1280","authenticated-orcid":false,"given":"Julia","family":"Mergner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Bultmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8543-6166","authenticated-orcid":false,"given":"Marc","family":"Schmidt-Supprian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinrich","family":"Leonhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9154-9469","authenticated-orcid":false,"given":"Marion","family":"Subklewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"von Bergwelt-Baildon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2224-7560","authenticated-orcid":false,"given":"Maria","family":"Colom\u00e9-Tatch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0987-7373","authenticated-orcid":false,"given":"Oliver","family":"Weigert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"1445_CR1","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"1445_CR2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"1445_CR3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1146\/annurev-immunol-020711-075032","volume":"30","author":"GD Victora","year":"2012","unstructured":"Victora GD, Nussenzweig MC. Germinal centers. Annu Rev Immunol. 2012;30:429\u201357.","journal-title":"Annu Rev Immunol"},{"key":"1445_CR4","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1182\/blood.V83.7.1856.1856","volume":"83","author":"T Yoshino","year":"1994","unstructured":"Yoshino T, Kondo E, Cao L, Takahashi K, Hayashi K, Nomura S, et al. Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood. 1994;83:1856\u201361.","journal-title":"Blood"},{"key":"1445_CR5","first-page":"1229","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood J Am Soc Hematol. 2022;140:1229\u201353.","journal-title":"Blood J Am Soc Hematol"},{"key":"1445_CR6","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, et al. The 5th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348.","journal-title":"Leukemia"},{"key":"1445_CR7","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/bjh.17990","volume":"196","author":"S Haebe","year":"2022","unstructured":"Haebe S, Keay W, Alig S, Mohr AW, Martin LK, Heide M, et al. The molecular ontogeny of follicular lymphoma: gene mutations succeeding the BCL2 translocation define common precursor cells. Br J Haematol. 2022;196:1381\u20137.","journal-title":"Br J Haematol"},{"key":"1445_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","volume":"5","author":"A Carbone","year":"2019","unstructured":"Carbone A, Roulland S, Gloghini A, Younes A, von Keudell G, L\u00f3pez-Guillermo A, et al. Follicular lymphoma. Nat Rev Dis Prim. 2019;5:83.","journal-title":"Nat Rev Dis Prim"},{"key":"1445_CR9","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1182\/blood-2017-07-737353","volume":"130","author":"O Weigert","year":"2017","unstructured":"Weigert O, Weinstock DM. The promises and challenges of using gene mutations for patient stratification in follicular lymphoma. Blood. 2017;130:1491\u20138.","journal-title":"Blood"},{"key":"1445_CR10","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood.2022015854","volume":"140","author":"L de Leval","year":"2022","unstructured":"de Leval L, Alizadeh AA, Bergsagel PL, Campo E, Davies A, Dogan A, et al. Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022;140:2193\u2013227.","journal-title":"Blood"},{"key":"1445_CR11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(15)00169-2","volume":"16","author":"A Pastore","year":"2015","unstructured":"Pastore A, Jurinovic V, Kridel R, Hoster E, Staiger AM, Szczepanowski M, et al. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry. Lancet Oncol. 2015;16:1111\u201322.","journal-title":"Lancet Oncol"},{"key":"1445_CR12","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1182\/blood-2016-05-717355","volume":"128","author":"V Jurinovic","year":"2016","unstructured":"Jurinovic V, Kridel R, Staiger AM, Szczepanowski M, Horn H, Dreyling MH, et al. Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy. Blood. 2016;128:1112\u201320.","journal-title":"Blood"},{"key":"1445_CR13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.cell.2018.09.032","volume":"175","author":"N Mashtalir","year":"2018","unstructured":"Mashtalir N, D\u2019Avino AR, Michel BC, Luo J, Pan J, Otto JE, et al. Modular organization and assembly of SWI\/SNF Family chromatin remodeling complexes. Cell. 2018;175:1272\u201388.e20.","journal-title":"Cell"},{"key":"1445_CR14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109943","volume":"37","author":"S Bl\u00fcmli","year":"2021","unstructured":"Bl\u00fcmli S, Wiechens N, Wu MY, Singh V, Gierlinski M, Schweikert G, et al. Acute depletion of the ARID1A subunit of SWI\/SNF complexes reveals distinct pathways for activation and repression of transcription. Cell Rep. 2021;37:109943.","journal-title":"Cell Rep"},{"key":"1445_CR15","doi-asserted-by":"crossref","unstructured":"Kelso TWR, Porter DK, Amaral ML, Shokhirev MN, Benner C, Hargreaves DC. Chromatin accessibility underlies synthetic lethality of SWI\/SNF subunits in ARID1A-mutant cancers. eLife. 2017;6:e30506.","DOI":"10.7554\/eLife.30506"},{"key":"1445_CR16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ng.3744","volume":"49","author":"R Mathur","year":"2017","unstructured":"Mathur R, Alver BH, San Roman AK, Wilson BG, Wang X, Agoston AT, et al. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Nat Genet. 2017;49:296\u2013302.","journal-title":"Nat Genet"},{"key":"1445_CR17","doi-asserted-by":"crossref","unstructured":"Kalmbach S, Grau M, Zapukhlyak M, Leich E, Jurinovic V, Hoster E, et al. Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms. Leukemia. 2023;37:2058\u201365.","DOI":"10.1038\/s41375-023-01995-w"},{"key":"1445_CR18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2159-8290.CD-11-0208","volume":"2","author":"O Weigert","year":"2012","unstructured":"Weigert O, Kopp N, Lane AA, Yoda A, Dahlberg SE, Neuberg D, et al. Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantation. Cancer Discov. 2012;2:47\u201355.","journal-title":"Cancer Discov"},{"key":"1445_CR19","doi-asserted-by":"crossref","first-page":"20380","DOI":"10.1073\/pnas.0810485105","volume":"105","author":"B Luo","year":"2008","unstructured":"Luo B, Cheung HW, Subramanian A, Sharifnia T, Okamoto M, Yang X, et al. Highly parallel identification of essential genes in cancer cells. Proc Natl Acad Sci USA. 2008;105:20380\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1445_CR20","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107522","volume":"31","author":"D Bararia","year":"2020","unstructured":"Bararia D, Hildebrand JA, Stolz S, Haebe S, Alig S, Trevisani CP, et al. Cathepsin S alterations induce a tumor-promoting immune microenvironment in follicular lymphoma. Cell Rep. 2020;31:107522.","journal-title":"Cell Rep"},{"key":"1445_CR21","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1101\/gr.240663.118","volume":"29","author":"L Garcia-Alonso","year":"2019","unstructured":"Garcia-Alonso L, Holland CH, Ibrahim MM, Turei D, Saez-Rodriguez J. Benchmark and integration of resources for the estimation of human transcription factor activities. Genome Res. 2019;29:1363\u201375.","journal-title":"Genome Res"},{"key":"1445_CR22","doi-asserted-by":"crossref","first-page":"194431","DOI":"10.1016\/j.bbagrm.2019.194431","volume":"1863","author":"CH Holland","year":"2020","unstructured":"Holland CH, Szalai B, Saez-Rodriguez J. Transfer of regulatory knowledge from human to mouse for functional genomics analysis. Biochim Biophys Acta (BBA)\u2014Gene Regul Mech. 2020;1863:194431.","journal-title":"Biochim Biophys Acta (BBA)\u2014Gene Regul Mech"},{"key":"1445_CR23","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-020-1949-z","volume":"21","author":"CH Holland","year":"2020","unstructured":"Holland CH, Tanevski J, Perales-Pat\u00f3n J, Gleixner J, Kumar MP, Mereu E, et al. Robustness and applicability of transcription factor and pathway analysis tools on single-cell RNA-seq data. Genome Biol. 2020;21:36.","journal-title":"Genome Biol"},{"key":"1445_CR24","doi-asserted-by":"crossref","first-page":"D412","DOI":"10.1093\/nar\/gkn760","volume":"37","author":"LJ Jensen","year":"2008","unstructured":"Jensen LJ, Kuhn M, Stark M, Chaffron S, Creevey C, Muller J, et al. STRING 8\u2014a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 2008;37:D412\u2013D6.","journal-title":"Nucleic Acids Res"},{"key":"1445_CR25","doi-asserted-by":"crossref","first-page":"e1000778","DOI":"10.1371\/journal.pgen.1000778","volume":"5","author":"PC Hollenhorst","year":"2009","unstructured":"Hollenhorst PC, Chandler KJ, Poulsen RL, Johnson WE, Speck NA, Graves BJ. DNA specificity determinants associate with distinct transcription factor functions. PLoS Genet. 2009;5:e1000778.","journal-title":"PLoS Genet"},{"key":"1445_CR26","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1101\/gad.1561707","volume":"21","author":"PC Hollenhorst","year":"2007","unstructured":"Hollenhorst PC, Shah AA, Hopkins C, Graves BJ. Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev. 2007;21:1882\u201394.","journal-title":"Genes Dev"},{"key":"1445_CR27","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/sj.cdd.4401186","volume":"10","author":"ME Peter","year":"2003","unstructured":"Peter ME, Krammer PH. The CD95(APO-1\/Fas) DISC and beyond. Cell Death Differ. 2003;10:26\u201335.","journal-title":"Cell Death Differ"},{"key":"1445_CR28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.genet.33.1.29","volume":"33","author":"S Nagata","year":"1999","unstructured":"Nagata S. Fas ligand-induced apoptosis. Annu Rev Genet. 1999;33:29\u201355.","journal-title":"Annu Rev Genet"},{"key":"1445_CR29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26213-y","volume":"12","author":"G Mendiratta","year":"2021","unstructured":"Mendiratta G, Ke E, Aziz M, Liarakos D, Tong M, Stites EC. Cancer gene mutation frequencies for the U.S. population. Nat Commun. 2021;12:5961.","journal-title":"Nat Commun"},{"key":"1445_CR30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214\u20138.","journal-title":"Nature"},{"key":"1445_CR31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1158\/2159-8290.CD-21-0271","volume":"11","author":"MP Zafra","year":"2021","unstructured":"Zafra MP, Dow LE. Revealing ARID1A function in gastric cancer from the bottom up. Cancer Discov. 2021;11:1327\u20139.","journal-title":"Cancer Discov"},{"key":"1445_CR32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0952-7915(97)80145-8","volume":"9","author":"Y-J Liu","year":"1997","unstructured":"Liu Y-J, de Bouteiller O, Fugier-Vivier I. Mechanisms of selection and differentiation in germinal centers. Curr Opin Immunol. 1997;9:256\u201362.","journal-title":"Curr Opin Immunol"},{"key":"1445_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1470-2045(21)00591-X","volume":"23","author":"CA Jacobson","year":"2022","unstructured":"Jacobson CA, Chavez JC, Sehgal AR, William BM, Munoz J, Salles G, et al. Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial. Lancet Oncol. 2022;23:91\u2013103.","journal-title":"Lancet Oncol"},{"key":"1445_CR34","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41591-021-01622-0","volume":"28","author":"NH Fowler","year":"2022","unstructured":"Fowler NH, Dickinson M, Dreyling M, Martinez-Lopez J, Kolstad A, Butler J, et al. Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial. Nat Med. 2022;28:325\u201332.","journal-title":"Nat Med"},{"key":"1445_CR35","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1158\/2159-8290.CD-20-0756","volume":"11","author":"R Upadhyay","year":"2021","unstructured":"Upadhyay R, Boiarsky JA, Pantsulaia G, Svensson-Arvelund J, Lin MJ, Wroblewska A, et al. A critical role for fas-mediated off-target tumor killing in T-cell immunotherapy. Cancer Discov. 2021;11:599\u2013613.","journal-title":"Cancer Discov"},{"key":"1445_CR36","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1182\/blood.2022015601","volume":"140","author":"H-JJ Cherng","year":"2022","unstructured":"Cherng H-JJ, Sun R, Sugg B, Irwin R, Yang H, Le CC, et al. Risk assessment with low-pass whole-genome sequencing of cell-free DNA before CD19 CAR T-cell therapy for large B-cell lymphoma. Blood. 2022;140:504\u201315.","journal-title":"Blood"},{"key":"1445_CR37","volume":"23","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Yang K, Jin L, Yang J, Huang S, et al. Impact of ARID1A and TP53 mutations in pediatric refractory or relapsed mature B-Cell lymphoma treated with CAR-T cell therapy. Cancer Cell Int. 2023;23:281.","journal-title":"Cancer Cell Int"},{"key":"1445_CR38","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adj5948","volume":"9","author":"J Staniek","year":"2024","unstructured":"Staniek J, Kalina T, Andrieux G, Boerries M, Janowska I, Fuentes M, et al. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells. Sci Immunol. 2024;9:eadj5948.","journal-title":"Sci Immunol"},{"key":"1445_CR39","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ccell.2024.02.010","volume":"42","author":"D Barisic","year":"2024","unstructured":"Barisic D, Chin CR, Meydan C, Teater M, Tsialta I, Mlynarczyk C, et al. ARID1A orchestrates SWI\/SNF-mediated sequential binding of transcription factors with ARID1A loss driving pre-memory B cell fate and lymphomagenesis. Cancer Cell. 2024;42:583\u2013604.e11.","journal-title":"Cancer Cell"},{"key":"1445_CR40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0092-8674(02)00690-6","volume":"109","author":"Q-L Li","year":"2002","unstructured":"Li Q-L, Ito K, Sakakura C, Fukamachi H, Inoue K-i, Chi X-Z, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 2002;109:113\u201324.","journal-title":"Cell"},{"key":"1445_CR41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1182\/blood-2008-02-140616","volume":"113","author":"KJ Cheung","year":"2009","unstructured":"Cheung KJ, Shah SP, Steidl C, Johnson N, Relander T, Telenius A, et al. Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances. Blood. 2009;113:137\u201348.","journal-title":"Blood"},{"key":"1445_CR42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/gcc.20617","volume":"48","author":"C Schwaenen","year":"2009","unstructured":"Schwaenen C, Viardot A, Berger H, Barth TFE, Bentink S, D\u00f6hner H, et al. Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes, Chromosomes Cancer. 2009;48:39\u201354.","journal-title":"Genes, Chromosomes Cancer"},{"key":"1445_CR43","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nbt.3080","volume":"33","author":"C Klijn","year":"2015","unstructured":"Klijn C, Durinck S, Stawiski EW, Haverty PM, Jiang Z, Liu H, et al. A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol. 2015;33:306\u201312.","journal-title":"Nat Biotechnol"},{"key":"1445_CR44","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013;8:2281\u2013308.","journal-title":"Nat Protoc"},{"key":"1445_CR45","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1038\/nprot.2006.468","volume":"1","author":"A Shevchenko","year":"2006","unstructured":"Shevchenko A, Tomas H, Havlis J, Olsen JV, Mann M. In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc. 2006;1:2856\u201360.","journal-title":"Nat Protoc"},{"key":"1445_CR46","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41596-018-0082-x","volume":"14","author":"CS Hughes","year":"2019","unstructured":"Hughes CS, Moggridge S, M\u00fcller T, Sorensen PH, Morin GB, Krijgsveld J. Single-pot, solid-phase-enhanced sample preparation for proteomics experiments. Nat Protoc. 2019;14:68\u201385.","journal-title":"Nat Protoc"},{"key":"1445_CR47","doi-asserted-by":"crossref","unstructured":"Zolg DP, Wilhelm M, Yu P, Knaute T, Zerweck J, Wenschuh H, et al. PROCAL: a set of 40 peptide standards for retention time indexing, column performance monitoring, and collision energy calibration. Proteomics. 2017;17:1700263.","DOI":"10.1002\/pmic.201700263"},{"key":"1445_CR48","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B MacLean","year":"2010","unstructured":"MacLean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26:966\u20138.","journal-title":"Bioinformatics"},{"key":"1445_CR49","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41592-019-0426-7","volume":"16","author":"S Gessulat","year":"2019","unstructured":"Gessulat S, Schmidt T, Zolg DP, Samaras P, Schnatbaum K, Zerweck J, et al. Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning. Nat methods. 2019;16:509\u201318.","journal-title":"Nat methods"},{"key":"1445_CR50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1046-2023(03)00123-3","volume":"31","author":"K Fischer","year":"2003","unstructured":"Fischer K, Mackensen A. The flow cytometric PKH-26 assay for the determination of T-cell mediated cytotoxic activity. Methods. 2003;31:135\u201342.","journal-title":"Methods"},{"key":"1445_CR51","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/s41587-023-01684-0","volume":"41","author":"A Gottschlich","year":"2023","unstructured":"Gottschlich A, Thomas M, Gr\u00fcnmeier R, Lesch S, Rohrbacher L, Igl V, et al. Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia. Nat Biotechnol. 2023;41:1618\u201332.","journal-title":"Nat Biotechnol"},{"key":"1445_CR52","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-022-02660-8","volume":"23","author":"A Janjic","year":"2022","unstructured":"Janjic A, Wange LE, Bagnoli JW, Geuder J, Nguyen P, Richter D, et al. Prime-seq, efficient and powerful bulk RNA sequencing. Genome Biol. 2022;23:88.","journal-title":"Genome Biol"},{"key":"1445_CR53","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/bioinformatics\/btu719","volume":"31","author":"G Renaud","year":"2014","unstructured":"Renaud G, Stenzel U, Maricic T, Wiebe V, Kelso J. deML: robust demultiplexing of Illumina ces using a likelihood-based approach. Bioinformatics. 2014;31:770\u20132.","journal-title":"Bioinformatics"},{"key":"1445_CR54","doi-asserted-by":"crossref","unstructured":"Parekh S, Ziegenhain C, Vieth B, Enard W, Hellmann I. zUMIs\u2014a fast and flexible pipeline to process RNA sequencing data with UMIs. GigaScience. 2018;7:giy059.","DOI":"10.1093\/gigascience\/giy059"},{"key":"1445_CR55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"1445_CR56","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nmeth.4396","volume":"14","author":"MR Corces","year":"2017","unstructured":"Corces MR, Trevino AE, Hamilton EG, Greenside PG, Sinnott-Armstrong NA, Vesuna S, et al. An improved ATAC-seq protocol reduces background and enables interrogation of frozen tissues. Nat methods. 2017;14:959\u201362.","journal-title":"Nat methods"},{"key":"1445_CR57","doi-asserted-by":"crossref","first-page":"D252","DOI":"10.1093\/nar\/gkx1106","volume":"46","author":"IV Kulakovskiy","year":"2017","unstructured":"Kulakovskiy IV, Vorontsov IE, Yevshin IS, Sharipov RN, Fedorova AD, Rumynskiy EI, et al. HOCOMOCO: towards a complete collection of transcription factor binding models for human and mouse via large-scale ChIP-Seq analysis. Nucleic Acid Res. 2017;46:D252\u201359.","journal-title":"Nucleic Acid Res"}],"container-title":["Cell Death &amp; Differentiation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01445-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01445-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01445-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T12:06:16Z","timestamp":1747656376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41418-025-01445-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1445"],"URL":"https:\/\/doi.org\/10.1038\/s41418-025-01445-3","relation":{},"ISSN":["1350-9047","1476-5403"],"issn-type":[{"value":"1350-9047","type":"print"},{"value":"1476-5403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"21 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MSub receives industry research support from Amgen, BMS\/Celgene, Gilead, Janssen, Miltenyi Biotec, Morphosys, Novartis, Roche, Seattle Genetics and Takeda; she serves as a consultant\/advisor to AvenCell, CDR-Life, Ichnos Sciences, Incyte Biosciences, Janssen, Miltenyi Biotec, Molecular Partners, Novartis, Pfizer and Takeda and serves on the speakers\u2019 bureau at Amgen, AstraZeneca, BMS\/Celgene, Gilead, GSK, Janssen, Novartis, Pfizer, Roche and Takeda. OW receives industry research support from Roche and Incyte; he serves as a consultant\/advisor to Beigene, Roche, Incyte and Epizyme. All other authors declare no relevant competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research was conducted in compliance with the relevant guidelines and regulations, as outlined in the Guidelines for Safeguarding Good Research Practice, Code of Conduct (German Research Foundation, revised version 1.1). Informed consent was obtained from all patients participating in clinical trials, including consent for the use of biopsy material for research purposes as previously described [, ]. Approval for molecular analyzes on human material was obtained from institutional and local ethics committees (LMU #223-14, LMU #276-14, LMU #056\/00, and LMU #539-15 fed).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}